Mapping Gaps: Geographic and Racial Disparities in CAR-T cell Therapy Access for Multiple Myeloma and B-ALL in the United States

Key Points

• Access to CAR-T cell therapy for multiple myeloma and B-ALL varies significantly across different regions in the U.S.
• Racial disparities were evident, with minority populations facing greater barriers to accessing CAR-T therapies.
• Data from analysis included various geographic regions, highlighting access issues irrespective of population size.
• These disparities point to systemic inequalities that may limit effective treatment for some patients.